✦ LIBER ✦

Incidence and importance of antibody responses to infliximab after maintenance or episodic treatment in Crohnâs disease

✍ Scribed by Hanauer, Stephen B; Wagner, Carrie L; Bala, Mohan; Mayer, Lloyd; Travers, Suzanne; Diamond, Robert H; Olson, Allan; Bao, Warren; Rutgeerts, Paul

Book ID: 120734067
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 217 KB
Volume: 2
Category: Article
ISSN: 1542-3565
DOI: 10.1016/S1542-3565(04)00238-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Association of Trough Serum Infliximab t

Association of Trough Serum Infliximab to Clinical Outcome After Scheduled Maintenance Treatment for Crohnâs Disease

✍ Maser, Elana A.; Villela, Renata; Silverberg, Mark S.; Greenberg, Gordon R. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 211 KB

Effect of antibodies to infliximab on in

Effect of antibodies to infliximab on infusion reaction and clinical response in patients with fistulizing Crohn's disease receiving maintenance treatment with infliximab

✍ Wagner, Carrie; Ford, Joyce; Marsters, Paul; Travers, Suzanne; Bao, Weihang; Dev 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 172 KB

Loss of Treatment Response to Infliximab

Loss of Treatment Response to Infliximab Maintenance Therapy in Crohn's Disease: A Payor Perspective

✍ Eric Qiong Wu; Parvez M. Mulani; Andrew Peng Yu; Jackson Tang; Paul F. Pollack 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 196 KB

Relationship of antibodies to infliximab

Relationship of antibodies to infliximab to duration of response and infusion reactions for Crohn's disease patients receiving episodic infliximab retreatment in ACCENT I

✍ Wagner, Carrie; Hanauer, Stephen B.; Bala, Mohan; Patel, Kamlesh; Travers, Suzan 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 186 KB

PGI23 Cost-Effectiveness of Episodic or

PGI23 Cost-Effectiveness of Episodic or Maintenance Infliximab Versus Standard Treatment in an Incidence Cohort of Crohn's Disease Patients With 10-Years Follow-Up

✍ S. Odes; D. Greenberg; H. Vardi; M. Friger; R. Stockbrugger; P. Munkholm 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

P577 Cost-effectiveness of episodic or m

P577 Cost-effectiveness of episodic or maintenance infliximab versus standard treatment in an incidence cohort of Crohn's disease patients with 10-years follow-up

✍ Odes, S.; Greenberg, D.; Vardi, H.; Friger, M.; Stockbrugger, R.; Munkholm, P. 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 52 KB

Incidence and importance of antibody responses to infliximab after maintenance or episodic treatment in Crohnâs disease

Incidence and importance of antibody responses to infliximab after maintenance or episodic treatment in Crohnâs disease